| Project/Area Number |
04670776
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Shiga University of Medical Science |
|---|
Principal Investigator |
SHIBATA Junsuke Shiga Univ.of Medical Science, School of Medicine, Associate Professor, 医学部, 助教授 (50128708)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KAWAGUCHI Akira Shiga Univ.of Medical Science, School of Medicine, Medical Doctor, 医学部, 医員
EGUCHI Yutaka Shiga Univ.of Medical Science, School of Medicine, Assistant Professor, 医学部, 助手 (00263054)
|
|---|
| Project Period (FY) |
1992 – 1993
|
| Project Status |
Completed (Fiscal Year 1993)
|
| Budget Amount *help |
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 1993: ¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1992: ¥400,000 (Direct Cost: ¥400,000)
|
|---|
| Keywords | Gastric Cancer / Colon Cancer / Unokinase-type Plasminogen Activator / Plasminogen Activator-Inhibitor-1 / Plasminogen Activator-Inhibitor-2 / Lymph Node Metastasis / Biological Malignancy / Prognosis / 食道癌 / u-PA / PAI-1 / PAI-2 / 線溶活性 |
|---|
| Research Abstract |
We examined immunohistochemically the localization of urokinase-type plasminogen activator(u-PA), plasminogen activator inhibitor(PAI)-1 and PAI-2 in both 111cases of gastric and 145 cases of colon cancer.
u-PA was immunostained in both gastric(44/111,39.6%)and colon (48/145,33.1%)cancer cells, confirmed the expression of mRNA in cancer cells using in situ hybridization. The expression of u-PA was more marked at the periphery of the tumor rather than in the central area. The five year survival of patients with u-PA positive was significantly lower than that of patients with u-PA negative (51.0% VS 77.5% in gastric cancer, 60.2% VS 80.9% in colon cancer).
PAI-1 antigen was detected in fibroblast cells (33/73)surroundings colon cancer cells. In these cases, lymph node metastasis seemed to be lower than that in PAI-1 negative cases. PAI-2 antigen was stained in both gastric (47/111,42.3%)and colon (33/73,45.2%)cancer cells. The intensity of PAI-2 staining was homogenously through the tumor, different pattern with that of u-PA staining. Clinically, u-PA negative and PAI-2 positive cases disclosed relatively well prognosis in five-year survival rate, whereas u-PA positive and PAI-2 negative cases showed poorer prognosis (81.8% VS 26.7% in gastric cancer, 90.9% VS 53.3% in colon cancer).
These findings indicates that u-PA is produced by cancer cells themselves, related to cancer invasion and metastasis, presumably useful for an index of biological malignancy, and PAI-1 and PAi-2 may have inhibitory effects in gastric and colon cancer.
|
